Analyze Diet

Topic:Disease control

Disease control in horses encompasses the strategies and measures implemented to prevent, manage, and eradicate infectious and non-infectious diseases within equine populations. This field involves the study of pathogen transmission, host-pathogen interactions, and the development of effective vaccination and biosecurity protocols. Disease control also includes monitoring and surveillance of equine health to identify outbreaks and implement timely interventions. Key aspects of disease control in horses involve understanding the epidemiology of equine diseases, improving diagnostic techniques, and enhancing treatment options. This page compiles peer-reviewed research studies and scholarly articles that explore various methodologies, technologies, and practices aimed at controlling diseases in horses, with a focus on improving overall equine health and welfare.
Investigation and management of an outbreak of abortion related to equine herpesvirus type 1 in unvaccinated ponies.
The Veterinary record    March 21, 2007   Volume 160, Issue 11 378-380 doi: 10.1136/vr.160.11.378
Irwin VL, Traub-Dargatz JL, Newton JR, Scase TJ, Davis-Poynter NJ, Nugent J, Creis L, Leaman TR, Smith KC.No abstract available
Investigations on outbreaks of African horse sickness in the surveillance zone in South Africa.
Revue scientifique et technique (International Office of Epizootics)    March 17, 2007   Volume 25, Issue 3 1097-1109 
Venter GJ, Koekemoer JJ, Paweska JT.Confirmed outbreaks of African horse sickness (AHS) occurred in the surveillance zone of the Western Cape in 1999 and 2004, both of which led to a two-year suspension on the export of horses. Light trap surveys in the outbreak areas showed that known vector competent Culicoides species, notably C. imicola, were abundant and present in numbers equal to those in the traditional AHS endemic areas. Isolations of AHS virus serotypes 1 and 7, equine encephalosis virus, and bluetongue virus from field-collected C. imicola in the surveillance zone demonstrated that this species was highly competent an...
Characterization of multidrug resistant Salmonella recovered from diseased animals.
Veterinary microbiology    March 7, 2007   Volume 123, Issue 1-3 122-132 doi: 10.1016/j.vetmic.2007.03.001
Zhao S, McDermott PF, White DG, Qaiyumi S, Friedman SL, Abbott JW, Glenn A, Ayers SL, Post KW, Fales WH, Wilson RB, Reggiardo C, Walker RD.Three hundred and eighty Salmonella isolates recovered from animal diagnostic samples obtained from four state veterinary diagnostic laboratories (AZ, NC, MO, and TN) between 2002 and 2003 were tested for antimicrobial susceptibilities and further characterized for bla(CMY) beta-lactamase genes, class 1 integrons and genetic relatedness using PFGE. Forty-seven serovars were identified, the most common being S. Typhimurium (26%), S. Heidelberg (9%), S, Dublin (8%), S. Newport (8%), S. Derby (7%), and S. Choleraesuis (7%). Three hundred and thirteen (82%) isolates were resistant to at least one ...
[Confidential reporting of prevention of farm animal cruelty. Slight rise in number of reports in 2006].
Tijdschrift voor diergeneeskunde    March 6, 2007   Volume 132, Issue 1 964-967 
de Groot SJ, Veling J.No abstract available
Avian titer development against West nile virus after extralabel use of an equine vaccine.
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians    February 28, 2007   Volume 36, Issue 2 257-264 doi: 10.1638/03-094.1
Johnson S.West Nile virus affects many animals, but the highest prevalence of morbidity and mortality is observed in birds, horses, and humans. The purpose of this study was to determine a protocol in birds of prey and corvids, using a vaccine developed for horses. The birds were assigned to five groups. Groups 1-4 received 0.25 ml, 0.5 ml, 0.75 ml, and 1.0 ml, respectively, and group 5 served as a control group. The greatest percentage of seroconversion (58.3%) was observed in the vaccine group that received a dose of 1.0 ml administered thrice, 3 wk apart. This report demonstrates that a vaccine devel...
Correlation between the induction of Th1 cytokines by an attenuated equine infectious anemia virus vaccine and protection against disease progression.
The Journal of general virology    February 28, 2007   Volume 88, Issue Pt 3 998-1004 doi: 10.1099/vir.0.82416-0
Zhang X, Wang Y, Liang H, Wei L, Xiang W, Shen R, Shao Y.The equine infectious anemia virus (EIAV) donkey-leukocyte attenuated vaccine (DLV) has been used to protect against equine infectious anaemia (EIA) disease for several decades in China. The attenuated mechanism and immunological protective mechanisms remain to be elucidated. To identify responses that correlate with the protection against disease, we immunized horses with DLV, followed by challenge with an EIAV wild-type strain LN. All vaccinated horses were asymptomatic and had a low level of virus replication (<10 copies ml-1). The expression level of cytokines including gamma interferon...
Efficacy of a canarypox-vectored recombinant vaccine expressing the hemagglutinin gene of equine influenza H3N8 virus in the protection of ponies from viral challenge.
American journal of veterinary research    February 3, 2007   Volume 68, Issue 2 213-219 doi: 10.2460/ajvr.68.2.213
Minke JM, Toulemonde CE, Coupier H, Guigal PM, Dinic S, Sindle T, Jessett D, Black L, Bublot M, Pardo MC, Audonnet JC.To determine onset and duration of immunity provided by a 2- or 3-dose series of a new canarypox-vectored recombinant vaccine for equine influenza virus (rCP-EIV vaccine) expressing the hemagglutinin genes of influenza H3N8 virus strains A/eq/Kentucky/94 and A/eq/Newmarket/2/93 in ponies. Methods: Forty-nine 1- to 3-year-old male Welsh Mountain Ponies that were seronegative for equine influenza virus. Methods: Vaccinated and control ponies were challenged with aerosolized influenza virus A/eq/Sussex/89 (H3N8), representative of the Eurasian lineage of circulating influenza viruses. In trial 1,...
The Horse Slaughter Act revisited.
Journal of the American Veterinary Medical Association    January 30, 2007   Volume 230, Issue 2 187 
Ward GM.No abstract available
The Horse Slaughter Act revisited.
Journal of the American Veterinary Medical Association    January 30, 2007   Volume 230, Issue 2 187-188 
Thompson BS.No abstract available
Response of Tabanidae (Diptera) to different natural attractants.
Journal of vector ecology : journal of the Society for Vector Ecology    January 26, 2007   Volume 31, Issue 2 262-265 doi: 10.3376/1081-1710(2006)31[262:rotdtd]2.0.co;2
Krcmar S, Mikuska A, Merdić E.The response of female tabanids to natural attractants was studied in the Monjoros Forest along the Nature Park Kopacki rit in eastern Croatia. Tabanids were caught in canopy traps baited with either aged cow, horse, sheep, or pig urine and also in unbaited traps. Tabanids were collected in a significantly higher numbers in traps baited with natural attractants compared to unbaited traps. The number of females of Tabanus bromius, Tabanus maculicornis, Tabanus tergestinus, and Hybomitra bimaculata collected from canopy traps baited with cow urine and traps baited with other natural attractants ...
Standardization and validation of an agar gel immunodiffusion test for the diagnosis of equine infectious anemia using a recombinant p26 antigen.
Veterinary microbiology    January 17, 2007   Volume 121, Issue 3-4 344-351 doi: 10.1016/j.vetmic.2007.01.007
Alvarez I, Gutierrez G, Vissani A, Rodriguez S, Barrandeguy M, Trono K.We developed and validated an agar gel immunodiffusion test (AGID) test for the diagnosis of equine infectious anemia (EIA) using as antigen the p26 protein of equine infectious anemia virus (EIAV) produced in the Escherichia coli expression system. The developed rp26-AGID test showed an excellent diagnostic relative sensitivity (100%) and specificity (100%) compared to a commercial AGID assay when 1855 field serum samples were analyzed. In addition, the rp26-AGID demonstrated to be a precise assay with excellent repeatability and reproducibility. In the analytical sensitivity trial, positive ...
Experiences with new generation vaccines against equine viral arteritis, West Nile disease and African horse sickness.
Vaccine    January 16, 2007   Volume 25, Issue 30 5577-5582 doi: 10.1016/j.vaccine.2006.12.058
MacLachlan NJ, Balasuriya UB, Davis NL, Collier M, Johnston RE, Ferraro GL, Guthrie AJ.Viral diseases constitute an ever growing threat to the horse industry worldwide because of the rapid movement of large numbers of horses for competition and breeding. A number of different types of vaccines are available for protective immunization of horses against viral diseases. Traditional inactivated and live-attenuated (modified live virus, MLV) virus vaccines remain popular and efficacious but recombinant vaccines are increasingly being developed and used, in part because of the perceived deficiencies of some existing products. New generation vaccines include MLVs with deletions and/or...
[Veterinarians–notables of the cities and the country. Some stages in their social ascent from the second half of the 18th century to the start of the 20th century]. Theves G.During the second half of the 18th century scientific veterinary medicine, a new profession was born as a result of economic and military needs--losses of cattle as a consequence of infectious diseases and the growing demand for treatment to be given to the horses of the armies. At first the members of the emerging occupation, who are generally of very modest origin, hardly differ from the traditional actors of animal health. At the beginning of the 19th century the governments employ a large number of veterinarians for official missions to combat infectious diseases. As from the second half o...
West Nile virus in horses.
The Veterinary record    December 26, 2006   Volume 159, Issue 26 895 
Drummond R.No abstract available
Rabies surveillance in the United States during 2005.
Journal of the American Veterinary Medical Association    December 19, 2006   Volume 229, Issue 12 1897-1911 doi: 10.2460/javma.229.12.1897
Blanton JD, Krebs JW, Hanlon CA, Rupprecht CE.During 2005, 49 states and Puerto Rico reported 6,417 cases of rabies in nonhuman animals and 1 case in a human being to the CDC, representing a 6.2% decrease from the 6,836 cases in nonhuman animals and 8 cases in human beings reported in 2004. Approximately 92% of the cases were in wildlife, and 8% were in domestic animals. Relative contributions by the major animal groups were as follows: 2,534 raccoons (39.5%), 1,478 skunks (23%), 1,408 bats (21.9%), 376 foxes (5.9%), 269 cats (4.2%), 93 cattle (1.5%), and 76 dogs (1.2%). Compared with numbers of reported cases in 2004, cases in 2005 decre...
Re: Double standard for horses promoted by AVMA and AAEP.
Journal of the American Veterinary Medical Association    December 14, 2006   Volume 229, Issue 11 1720 
Normile JA.No abstract available
Re: AVMA position on horse slaughter.
Journal of the American Veterinary Medical Association    December 14, 2006   Volume 229, Issue 11 1720-1721 
Marek K.No abstract available
[Occurrence and treatment of Bovicola (Damalinia) equi (Linnaeus, 1758) infestation on a thoroughbred horse farm.].
Turkiye parazitolojii dergisi    December 13, 2006   Volume 29, Issue 3 183-184 
Güleğen E, Cirak VY.Lice infestations of horses occur mainly during winter months and are characterized by severe pruritus and an unkempt coat. Two lice have been described for equines namely Bovicola (Damalinia) equi and Haemotopinus asini. There is a scarcity of data on the occurrence and prevalence rates of these horse pathogens in Turkey. This paper reports a thoroughbred farm, in which two horses were found to be infested with B. equi. The horses were treated with propoxur and no lice or nymphs could be found after treatment for10 days.
West Nile virus in horses.
The Veterinary record    December 13, 2006   Volume 159, Issue 24 823 
Coumbe K, Mair T, Samuelson J, Sinclair D.No abstract available
Development and registration of recombinant veterinary vaccines. The example of the canarypox vector platform.
Vaccine    December 8, 2006   Volume 25, Issue 30 5606-5612 doi: 10.1016/j.vaccine.2006.11.066
Poulet H, Minke J, Pardo MC, Juillard V, Nordgren B, Audonnet JC.The canarypox vaccine vector (ALVAC) technology has been used to develop and license several vaccines for companion animals and horses in the European Union and USA. ALVAC is a ubiquitous vector with high biosafety since it is non-replicative in mammalians, is genetically and physically stable, and able to induce both humoral and cell-mediated immune responses against the expressed transgene product. Specific rules apply for the development and registration of recombinant vector vaccines. The biology of the vector as well as the recombinant virus must be thoroughly documented to allow the risk...
West Nile virus in horses.
The Veterinary record    December 5, 2006   Volume 159, Issue 23 787-788 
Chandler K.No abstract available
Prevalence of Trypanosoma evansi infection in equines and camels in the Punjab region, Pakistan.
Annals of the New York Academy of Sciences    December 1, 2006   Volume 1081 322-324 doi: 10.1196/annals.1373.043
Ul Hasan M, Muhammad G, Gutierrez C, Iqbal Z, Shakoor A, Jabbar A.A cross-sectional study has been carried out in order to determine the prevalence of Trypanosoma evansi infection in susceptible hosts in the Punjab region (Pakistan). A total of 170 equines and 150 dromedary camels were examined. Five (3.3%) and 6 (4%) camels were positive at parasitological and serological examination, respectively. None of the equines tested positive at any method. These results seem to indicate that T. evansi infection has a relatively low prevalence in the Punjab region. However, efforts must be done in order to establish control measures in affected herds and avoid disse...
Serological assessment of West Nile fever virus activity in the pastoral system of Ferlo, Senegal.
Annals of the New York Academy of Sciences    December 1, 2006   Volume 1081 216-225 doi: 10.1196/annals.1373.026
Chevalier V, Lancelot R, Diaité A, Mondet B, Sall B, De Lamballerie X.The Ferlo area (north-central Senegal) is characterized by a system of temporary ponds favorable to arboviruses among which West Nile fever (WNF) was already identified. During the rainy season in 2003, a serological study was undertaken on horses to assess the activity of the WNF virus (WNFV) in Barkedji (Ferlo). The observed serological prevalence rate was 78.3% for neutralizing antibodies, with a 95% confidence interval (CI) of [64.0, 92.7]. This prevalence rate significantly increased with age (P = 10(-5)). This study confirmed that WNF was endemic in the Ferlo. The transmission risks depe...
New findings on anaplasmosis caused by infection with Anaplasma phagocytophilum.
Annals of the New York Academy of Sciences    December 1, 2006   Volume 1081 360-370 doi: 10.1196/annals.1373.053
Lillini E, Macrì G, Proietti G, Scarpulla M.Ixodes ricinus (I. ricinus) is one of the vectors of Anaplasma phagocytophilum (A. phagocytophilum) in Europe, in which rates of infection range from 1.9% to 34%. In 1998, human granulocytic ehrlichiosis-like (HGE-like) Ehrlichia DNA was detected in Italy, by PCR technique in one I. ricinus nymph out of 55 ticks that were examined. In 1996, 6.3% of 310 human sera in high-risk subjects from Italy were found positive for antibodies to Ehrlichia phagocytophila (E. phagocytophila). In the same year, the authors reported the first case of equine granulocytic ehrlichiosis. In 1997, only 2 out of 563...
West Nile virus in Guadeloupe: introduction, spread, and decrease in circulation level: 2002-2005.
Annals of the New York Academy of Sciences    December 1, 2006   Volume 1081 206-215 doi: 10.1196/annals.1373.025
Lefrançois T, Blitvich BJ, Pradel J, Molia S, Vachiéry N, Martinez D.In July 2002, a surveillance system was implemented on Guadeloupe to detect for the potential introduction and monitor the spread of West Nile virus (WNV). From 2002 to 2004, equines and chickens were serologically assayed for antibodies to WNV by IgG and IgM enzyme-linked immunosorbent assay (ELISA), epitope-blocking ELISA, and plaque reduction neutralization tests. After introduction, probably through migratory birds at the end of 2001, many seroconversions occurred between July and October 2002 resulting in a high seroprevalence (19.3%) in equines in 2003. WNV circulation levels decreased d...
Monoclonal antibody-based competitive enzyme-linked immunosorbent assay for detecting and quantifying West Nile virus-neutralizing antibodies in horse sera.
Clinical and vaccine immunology : CVI    November 29, 2006   Volume 14, Issue 2 134-138 doi: 10.1128/CVI.00322-06
Choi KS, Ko YJ, Nah JJ, Kim YJ, Kang SY, Yoon KJ, Joo YS.A rapid immunoassay for detecting and quantifying West Nile virus (WNV)-neutralizing antibodies in sera was developed as an alternative to the plaque reduction neutralization test (PRNT), the gold standard test for WNV. The assay is a competitive, enzyme-linked immunosorbent assay using neutralizing monoclonal antibody 5E8 (NT-ELISA). A cutoff percent inhibition (PI) value of 35% (mean PI plus 3 standard deviations), with a specificity of 99%, was established based on analysis of 246 serum samples from horses free of WNV. The NT-ELISA detected neutralizing antibodies in all sera collected 7 or...
West Nile virus in horses.
The Veterinary record    November 23, 2006   Volume 159, Issue 21 723 doi: 10.1136/vr.159.21.723
Durham A.No abstract available
The influence of distance on movement of tabanids (Diptera: Tabanidae) between horses.
Veterinary parasitology    November 16, 2006   Volume 144, Issue 3-4 380-384 doi: 10.1016/j.vetpar.2006.09.041
Barros AT, Foil LD.Two studies evaluated the potential use of spatial barriers to reduce the mechanical transmission of disease agents by tabanids in the Pantanal region of Brazil. Tabanids at stations separated by four different distances (5, 10, 25, and 50m) were marked. In the first study, tabanids were marked and allowed to feed until engorgement or natural interruption occurred and captured if they transferred to the other horse. A total of 2847 tabanids belonging to nine different species were marked. The percentage of tabanids that moved between horses was 10.5 at 5m, 6.8 at 10m, and 4.6 at 25m. In the se...
Pathogenicity and immunogenicity of equine herpesvirus type 1 mutants defective in either gI or gE gene in murine and hamster models.
The Journal of veterinary medical science    November 7, 2006   Volume 68, Issue 10 1029-1038 doi: 10.1292/jvms.68.1029
Tsujimura K, Yamanaka T, Kondo T, Fukushi H, Matsumura T.To develop a live vaccine for equine herpesvirus type 1 (EHV-1), two EHV-1 mutants containing no heterogeneous DNA, DeltagI and DeltagE, were constructed with deletions in the open reading frame of either glycoprotein I (gI) or E (gE), respectively. In equine cell culture, deletion mutants formed smaller plaques than the parental and revertant viruses, but the one-step growth patterns of the deletion mutants and the parental strain were approximately the same. These results suggest that both gI and gE contribute to the ability of EHV-1 to spread directly from cell-to-cell, but that these glyco...
Questions applications and conclusions in equine herpesvirus study.
American journal of veterinary research    November 3, 2006   Volume 67, Issue 11 1820 doi: 10.2460/ajvr.67.11.1820
Reilly FK.No abstract available
1 55 56 57 58 59 120